| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gideon Koren, Hedvig M E Norden. Selective serotonin reuptake inhibitors and malformations: case closed? Seminars in fetal & neonatal medicine. vol 18. issue 1. 2013-06-24. PMID:23228547. |
selective serotonin reuptake inhibitors (ssris) are widely used by pregnant women due to the high rates of depression among reproductive-age women. |
2013-06-24 |
2023-08-12 |
Not clear |
| Veronika Kiryanova, Victoria M Smith, Richard H Dyck, Michael C Antl. The effects of perinatal fluoxetine treatment on the circadian system of the adult mouse. Psychopharmacology. vol 225. issue 3. 2013-06-21. PMID:22972413. |
depression is prevalent among women of childbearing age and is frequently treated with selective serotonin reuptake inhibitors (ssris). |
2013-06-21 |
2023-08-12 |
mouse |
| Bassim Msa Mohamed, Sawsan Aboul-Fotouh, Eman A Ibrahim, Hanan Shehata, Amal A Mansour, Nemat Az Yassin, Wafaa El-Eraky, Ahmed M Abdel-Tawa. Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-α and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats. Neuropsychiatric disease and treatment. vol 9. 2013-06-21. PMID:23785234. |
this study aimed to investigate the role of tumor necrosis factor (tnf)-α and the neuronal nitric oxide synthase enzyme in dysregulation of indoleamine 2,3-dioxygenase (ido) enzyme, and hence serotonin availability in chronic mild stress (cms), an animal model of depression. |
2013-06-21 |
2023-08-12 |
rat |
| George W Brown, Maria Ban, Thomas K J Craig, Tirril O Harris, Joe Herbert, Rudolf Uhe. Serotonin transporter length polymorphism, childhood maltreatment, and chronic depression: a specific gene-environment interaction. Depression and anxiety. vol 30. issue 1. 2013-06-20. PMID:22847957. |
serotonin transporter length polymorphism, childhood maltreatment, and chronic depression: a specific gene-environment interaction. |
2013-06-20 |
2023-08-12 |
Not clear |
| George W Brown, Maria Ban, Thomas K J Craig, Tirril O Harris, Joe Herbert, Rudolf Uhe. Serotonin transporter length polymorphism, childhood maltreatment, and chronic depression: a specific gene-environment interaction. Depression and anxiety. vol 30. issue 1. 2013-06-20. PMID:22847957. |
key questions about the interaction between the serotonin transporter length polymorphism (5-httlpr) and stress in the etiology of depression remain unresolved. |
2013-06-20 |
2023-08-12 |
Not clear |
| Francesc Artiga. Serotonin receptors involved in antidepressant effects. Pharmacology & therapeutics. vol 137. issue 1. 2013-06-20. PMID:23022360. |
the neurotransmitter serotonin (5-hdroxytryptamine; 5-ht) has been implicated in the pathophysiology and treatment of major depression since the serendipitous discovery of antidepressant drugs in the 1950s. |
2013-06-20 |
2023-08-12 |
Not clear |
| Iain M McIntyre, Phyllis Mallet. Sertraline concentrations and postmortem redistribution. Forensic science international. vol 223. issue 1-3. 2013-06-20. PMID:23131307. |
sertraline is a commonly prescribed selective inhibitor of serotonin uptake used for the treatment of mental depression and anxiety. |
2013-06-20 |
2023-08-12 |
Not clear |
| Paul O Wilkinson, Claire Harris, Raphael Kelvin, Bernadka Dubicka, Ian M Goodye. Associations between adolescent depression and parental mental health, before and after treatment of adolescent depression. European child & adolescent psychiatry. vol 22. issue 1. 2013-06-17. PMID:22836732. |
data were collected as part of the adolescent depression antidepressants and psychotherapy trial, a randomised controlled trial of selective serotonin reuptake inhibitors with and without cognitive behaviour therapy in 208 clinic-recruited adolescents with major depression. |
2013-06-17 |
2023-08-12 |
Not clear |
| E Kirilly, L Hunyady, G Bagd. Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists. Journal of neural transmission (Vienna, Austria : 1996). vol 120. issue 1. 2013-06-14. PMID:22990678. |
there is strong evidence that endocannabinoids modulate signaling of serotonin and noradrenaline, which play key roles in the pathophysiology and treatment of anxiety and depression. |
2013-06-14 |
2023-08-12 |
human |
| M Ranieri, P Putignano, P Fiore, A Santamato, G Megna, R G Bellomo, G Cristella, R Saggini, M Megn. Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis. International journal of immunopathology and pharmacology. vol 25. issue 1 Suppl. 2013-06-12. PMID:22652162. |
the drugs most commonly offered, for treatment of depression in patients with ms, are selective serotonin reuptake inhibitors (ssris), reuptake inhibitors of serotonin and norepinephrine (snris) and tricyclic antidepressants (tca). |
2013-06-12 |
2023-08-12 |
Not clear |
| Hong Liang Tey, Joanna Wallengren, Gil Yosipovitc. Psychosomatic factors in pruritus. Clinics in dermatology. vol 31. issue 1. 2013-06-11. PMID:23245971. |
pharmcotherapeutic agents that are useful for chronic pruritus with comorbid depression and/or anxiety comprise selective serotonin reuptake inhibitors, mirtazapine, tricyclic antidepressants (amitriptyline and doxepin), and anticonvulsants (gabapentin, pregabalin); the role of neurokinin receptor-1 antagonists awaits verification. |
2013-06-11 |
2023-08-12 |
Not clear |
| Ashley Martinez, Andrey Finegersh, Dara M Cannon, Irene Dustin, Alison Nugent, Peter Herscovitch, William H Theodor. The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy. Neurology. vol 80. issue 16. 2013-06-11. PMID:23516322. |
to study 5-ht transport and 5-ht1a receptors in temporal lobe epilepsy (tle) and depression. |
2013-06-11 |
2023-08-12 |
Not clear |
| Emelie Stenman, Asa Lilj. Increased monoaminergic neurotransmission improves compliance with physical activity recommendations in depressed patients with fatigue. Medical hypotheses. vol 80. issue 1. 2013-06-05. PMID:23127500. |
some studies have, however, suggested that the most frequently used antidepressants, selective serotonin reuptake inhibitors (ssris), contribute to fatigue, which is a common residual symptom associated with depression and the target of the proposed study. |
2013-06-05 |
2023-08-12 |
Not clear |
| Michael V Relf, Shelly Eisbach, Kayj Nash Okine, Terry War. Evidence-based clinical practice guidelines for managing depression in persons living with HIV. The Journal of the Association of Nurses in AIDS Care : JANAC. vol 24. issue 1 Suppl. 2013-06-05. PMID:23290374. |
first-line treatment regimens for depression include selective serotonin reuptake inhibitors (ssris), cognitive behavioral therapy (cbt), or a combination of ssri and cbt. |
2013-06-05 |
2023-08-12 |
Not clear |
| J D A Olivier, H Akerud, H Kaihola, J L Pawluski, A Skalkidou, U Högberg, I Sundström-Poroma. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Frontiers in cellular neuroscience. vol 7. 2013-06-05. PMID:23734100. |
the effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. |
2013-06-05 |
2023-08-12 |
Not clear |
| J D A Olivier, H Akerud, H Kaihola, J L Pawluski, A Skalkidou, U Högberg, I Sundström-Poroma. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Frontiers in cellular neuroscience. vol 7. 2013-06-05. PMID:23734100. |
currently, common treatment for maternal depression has been the selective serotonin reuptake inhibitor medications (ssris) which are used by 2-3% of pregnant women in the nordic countries and by up to 10% of pregnant women in the united states. |
2013-06-05 |
2023-08-12 |
Not clear |
| Güliz Gürel, Megan A Gustafson, Judy S Pepper, H Robert Horvitz, Michael R Koell. Receptors and other signaling proteins required for serotonin control of locomotion in Caenorhabditis elegans. Genetics. vol 192. issue 4. 2013-06-03. PMID:23023001. |
a better understanding of the molecular mechanisms of signaling by the neurotransmitter serotonin is required to assess the hypothesis that defects in serotonin signaling underlie depression in humans. |
2013-06-03 |
2023-08-12 |
caenorhabditis_elegans |
| R Lanzenberger, P Baldinger, A Hahn, J Ungersboeck, M Mitterhauser, D Winkler, Z Micskei, P Stein, G Karanikas, W Wadsak, S Kasper, R Fre. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Molecular psychiatry. vol 18. issue 1. 2013-05-30. PMID:22751491. |
further, alterations of the 5-ht(1a) receptor are consistently reported in depression. |
2013-05-30 |
2023-08-12 |
human |
| R Lanzenberger, P Baldinger, A Hahn, J Ungersboeck, M Mitterhauser, D Winkler, Z Micskei, P Stein, G Karanikas, W Wadsak, S Kasper, R Fre. Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET. Molecular psychiatry. vol 18. issue 1. 2013-05-30. PMID:22751491. |
to elucidate the effect of ect on 5-ht(1a) receptor binding, 12 subjects with severe treatment-resistant major depression underwent three positron emission tomography (pet) measurements using the highly selective radioligand [carbonyl-(11)c]way100635, twice before (test-retest variability) and once after 10.08±2.35 ect sessions. |
2013-05-30 |
2023-08-12 |
human |
| Kenji Hashimot. Understanding depression: linking brain-derived neurotrophic factor, transglutaminase 2 and serotonin. Expert review of neurotherapeutics. vol 13. issue 1. 2013-05-30. PMID:23253384. |
understanding depression: linking brain-derived neurotrophic factor, transglutaminase 2 and serotonin. |
2013-05-30 |
2023-08-12 |
Not clear |